. .. Protocole-d'imagerie,

. .. Analyse-d'image,

. .. Analyse-statistique,

. .. Résultats,

. .. Discussion,

. .. Conclusion,

. .. Remerciements,

. .. References,

. .. Annexes, 1 : Caractéristiques démographiques de la population d'étude

C. Fletcher, K. K. Unni, F. Mertens, and W. , Pathology and genetics of tumours of soft tissue and bone; [the WHO classification of tumours of soft tissue and bone presented in this book reflects the views of a working group, 2002.

S. Salas, A. Dufresne, B. Bui, J. Blay, P. Terrier et al., Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation, J Clin Oncol, vol.29, issue.26, pp.3553-3561, 2011.

C. J. Shields, D. C. Winter, W. O. Kirwan, and H. P. Redmond, Desmoid tumours, Eur J Surg Oncol, vol.27, issue.8, pp.701-707, 2001.

A. Gronchi, C. Colombo, L. Péchoux, C. , D. Tos et al., Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm-a position paper from the Italian and the French Sarcoma Group, Ann Oncol, vol.25, issue.3, pp.578-83, 2014.

S. Bonvalot, A. Desai, S. Coppola, L. Pechoux, C. Terrier et al., The treatment of desmoid tumors: a stepwise clinical approach, Ann Oncol, vol.23, issue.10, pp.158-66, 2012.

S. Bonvalot, F. Rimareix, S. Causeret, L. Péchoux, C. Boulet et al., Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient, Ann Surg Oncol, vol.16, issue.12, pp.3350-3357, 2009.

A. B. Shinagare, N. H. Ramaiya, J. P. Jagannathan, K. M. Krajewski, A. A. Giardino et al., A to Z of Desmoid Tumors, Am J Roentgenol, vol.197, issue.6, pp.1008-1022, 2011.

J. L. Kujak, P. T. Liu, G. B. Johnson, and M. R. Callstrom, Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors, Skeletal Radiol, vol.39, issue.2, pp.175-82, 2010.

R. Grimer, J. I. Peake, D. Seddon, and B. , Guidelines for the Management of Soft Tissue Sarcomas, Sarcoma, vol.2010, pp.1-15, 2010.

B. Kasper, C. Baumgarten, S. Bonvalot, R. Haas, F. Haller et al., Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients' and professionals' expertise -A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative, Eur J Cancer, vol.51, issue.2, pp.127-163, 2015.

, Nationwide Trends in the Current Management of Desmoid (Aggressive) Fibromatosis -Clinical Oncology, 2019.

G. Teixeira, P. A. Chanson, A. Verhaeghe, J. Lecocq, S. Louis et al., Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study, Diagn Interv Imaging, 2019.

G. Castellazzi, D. Vanel, L. Cesne, A. , L. Pechoux et al., Can the MRI signal of aggressive fibromatosis be used to predict its behavior?, Eur J Radiol, vol.69, issue.2, pp.222-231, 2009.

V. P. De-camargo, M. L. Keohan, D. 'adamo, D. R. Antonescu, C. R. Brennan et al., Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor), Cancer, 2010.

M. Aghighi, J. Boe, J. Rosenberg, V. Eyben, R. Gawande et al., Threedimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome, Radiology, vol.280, issue.3, pp.905-920, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01482352

S. Stacchiotti, P. Collini, A. Messina, C. Morosi, M. Barisella et al., High-Grade Soft-Tissue Sarcomas: Tumor Response Assessment-Pilot Study to Assess the Correlation between Radiologic and Pathologic Response by Using RECIST and Choi Criteria, Radiology, vol.251, issue.2, pp.447-56, 2009.

M. R. Cassidy, R. A. Lefkowitz, N. Long, L. Qin, A. Kirane et al., Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study, Ann Surg, 2001.

P. D. Mozley, C. Bendtsen, B. Zhao, L. H. Schwartz, M. Thorn et al., Measurement of Tumor Volumes Improves RECIST-Based Response Assessments in Advanced Lung Cancer, Transl Oncol, vol.5, issue.1, pp.19-25, 2012.

K. M. Krajewski, M. Nishino, Y. Franchetti, N. H. Ramaiya, A. D. Van-den-abbeele et al., Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: Implications for alternative response criteria: Observer Variation in Tumor Measures, Cancer, vol.120, issue.5, pp.711-732, 2014.

L. H. Schwartz, S. Litière, E. De-vries, R. Ford, S. Gwyther et al., RECIST 1.1-Update and clarification: From the RECIST committee, Eur J Cancer, vol.62, pp.132-139, 2016.

P. J. Sheth, S. Del-moral, B. A. Wilky, J. C. Trent, J. Cohen et al., Desmoid fibromatosis: MRI features of response to systemic therapy, Skeletal Radiol, vol.45, issue.10, pp.1365-73, 2016.

M. Burke, J. R. Anderson, S. C. Kao, D. Rodeberg, S. J. Qualman et al., Assessment of Response to Induction Therapy and Its Influence on 5-Year Failure-Free Survival in Group III Rhabdomyosarcoma: The Intergroup Rhabdomyosarcoma Study-IV Experience-A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group, J Clin Oncol, vol.25, issue.31, pp.4909-4922, 2007.

J. J. Bissler, J. M. Elwing, V. J. Schmithorst, and J. Bean, Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis, N Engl J Med, vol.12, 2008.

A. Dangoor, B. Seddon, C. Gerrand, R. Grimer, J. Whelan et al., UK guidelines for the management of soft tissue sarcomas, Clin Sarcoma Res, 2016.

, , vol.6

M. Havaei, A. Davy, D. Warde-farley, A. Biard, A. Courville et al., Brain tumor segmentation with Deep Neural Networks. Med Image Anal, vol.35, pp.18-31, 2017.